Clinical practice guidelines for the diagnosis and treatment of scabies.
diagnostics
elimination
infestations
neglected tropical diseases
prevention
scabies
treatment
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
23 Jun 2024
23 Jun 2024
Historique:
revised:
21
05
2024
received:
31
03
2024
accepted:
29
05
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
aheadofprint
Résumé
Scabies, caused by the Sarcoptes scabiei var hominis mite burrowing into the skin, is a highly contagious disease characterized by intense nocturnal itching. Its global impact is considerable, affecting more than 200 million individuals annually and posing significant challenges to healthcare systems worldwide. Transmission occurs primarily through direct skin-to-skin contact, contributing to its widespread prevalence and emergence as a substantial public health concern affecting large populations. This review presents consensus-based clinical practice guidelines for diagnosing and managing scabies, developed through the fuzzy Delphi method by dermatology, parasitology, pediatrics, pharmacology, and public health experts. The presence of burrows containing adult female mites, their eggs, and excreta is the diagnostic hallmark of scabies. Definitive diagnosis typically involves direct microscopic examination of skin scrapings obtained from these burrows, although dermoscopy has become a diagnostic tool in clinical practice. Treatment modalities encompass topical agents, such as permethrin, balsam of Peru, precipitated sulfur, and benzyl benzoate. In cases where topical therapy proves inadequate or in instances of crusted scabies, oral ivermectin is recommended as a systemic treatment option. This comprehensive approach addresses the diagnostic and therapeutic challenges associated with scabies, optimizing patient care, and management outcomes.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). International Journal of Dermatology published by Wiley Periodicals LLC on behalf of the International Society of Dermatology.
Références
World Health Organization. Scabies. Available from: https://www.who.int/news‐room/fact‐sheets/detail/scabies (last accessed 09 December 2023).
Ständer S, Ständer S. Itch in scabies‐what do we know? Front Med (Lausanne). 2021;8:628392.
Chosidow O, Hay RJ. Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings. Lancet Infect Dis. 2019;19:454–456.
Mellanby K. Scabies. 2nd ed. UK: Hampton: E. W. Classey; 1972.
Mumcuoğlu KY, Taylan‐Özkan A, Gazi U. Uyuz etkeninin entomolojik ve immünolojik özellikleri. In: Uzun S, Durdu M, editors. Her Yönüyle Uyuz. Antalya: Kongre Kitabevi; 2023. p. 21–34.
Arlian LG, Estes SA, Vyszenski‐Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol. 1988;19:806–811.
Arlian LG, Runyan RA, Sorlie LB, Estes SA. Host‐seeking behavior of Sarcoptes scabiei. J Am Acad Dermatol. 1984;11:594–598.
Uzun S. Uyuzun klinik özellikleri ve ayırıcı tanısı. In: Uzun S, Durdu M, editors. Her Yönüyle Uyuz. Antalya: Kongre Kitabevi; 2023. p. 49–68.
Cohen PR. Two for one: concurrent acquisition of molluscum contagiosum infection and scabies infestation after a single sexual encounter. Cureus. 2021;13:e20780.
Montaño‐Castellón I, Marconi CSC, Saffe C, Brites C. Clinical and laboratory outcomes in HIV‐1 and HTLV‐1/2 coinfection: a systematic review. Front Public Health. 2022;10:820727.
Mellanby K. Transmission of scabies. Br Med J. 1941;2:405–406.
Johnson CG, Mellanby K. The parasitology of human scabies. Parasitology. 1942;34:285–290.
Kouotou EA, Nansseu JRN, Sangare A, Bogne LLM, Sieleunou I, Adegbidi H, et al. Burden of human scabies in sub‐Saharan African prisons: evidence from the west region of Cameroon. Australas J Dermatol. 2018;59:e6–e10.
Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367:1767–1774.
Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: scabies. J Am Acad Dermatol. 2020;82:533–548.
Korycinska J, Dzika E, Kloch M. Epidemiology of scabies in relation to socio‐economic and selected climatic factors in north‐east Poland. Ann Agric Environ Med. 2020;27:374–378.
Tefera S, Teferi M, Ayalew A, Belete T, Hadush H. Prevalence of scabies and associated factors among primary school children in Raya Alamata District, Tigray, Ethiopia, 2017/2018. J Infect Dis Epidemiol. 2020;6:154.
Leung AKC, Lam JM, Leong KF. Scabies: a neglected global disease. Curr Pediatr Rev. 2020;16:33–42.
Lassa S, Campbell MJ, Bennett CE. Epidemiology of scabies prevalence in the U.K. from general practice records. Br J Dermatol. 2011;164:1329–1334.
Worku ED, Asemahagn MA, Endalifer ML. Determinants of scabies outbreak in Takusa district of Amhara Region, Northwest Ethiopia. J Public Health Afr. 2020;11:1325.
Aktas H, Cebecik A. Changes in incidence and age distribution of scabies: a retrospective cohort study in a tertiary hospital. Arch Clin Exp Med. 2019;4:21–24.
Özden MG, Ertürk K, Kartal SP, Yayli S, Göktay F, Doğramacı CA, et al. An extraordinary outbreak of scabies in Turkey. J Eur Acad Dermatol Venereol. 2020;34:e818–e820.
Baykal C, Atci T, Kutlay A, Baykut B, Türkoğlu Z. Scabies outbreak in Turkey in 2018‐2019. J Eur Acad Dermatol Venereol. 2021;35:e384–e385.
Karaca Ural Z, Çatak B, Ağaoğlu E. Prevalence of scabies in the Covid‐19 pandemic period and determination of risk factors for scabies: a hospital‐based cross‐sectional study in Northeast Turkey. Acta Parasitol. 2022;67:802–808.
Orion E, Matz H, Wolf R. Ectoparasitic sexually transmitted diseases: scabies and pediculosis. Clin Dermatol. 2004;22:513–519.
Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, et al. The 2020 International alliance for the control of scabies consensus criteria for the diagnosis of scabies. Br J Dermatol. 2020;183:808–820.
Tüzün Y, Parlak AH. Uyuz, bitlenme ve diğer paraziter hastalıklar. In: Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksungur VL, editors. Dermatoloji. 3rd ed. İstanbul: Nobel Tıp Kitapevleri; 2008. p. 683–728.
Uzun S, Durdu M. Derimiz için öneriler. 1st ed. İstanbul: İstanbul Tıp Kitapevleri; 2021. p. 668–673.
Walton SF. The immunology of susceptibility and resistance to scabies. Parasite Immunol. 2010;32:532–540.
Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy‐eight patients and a review of the literature. J Infect. 2005;50:375–381.
Raffi J, Suresh R, Butler DC. Review of scabies in the elderly. Dermatol Ther (Heidelb). 2019;9:623–630.
Executive committee of guideline for the diagnosis and treatment of scabies. Guideline for the diagnosis and treatment of scabies in Japan (third edition): executive committee of guideline for the diagnosis and treatment of scabies. J Dermatol. 2017;44:991–1014.
Karthikeyan K. Crusted scabies. Indian J Dermatol Venereol Leprol. 2009;75:340–347.
Chandler DJ, Fuller LC. A review of scabies: an infestation more than skin deep. Dermatology. 2019;235:79–90.
Dia D, Dieng MT, Ndiaye AM, Ndiaye B, Develoux M. La gale croûteuse à Dakar a propos de 11 cas observés en une année [Crusted scabies in Dakar apropos of 11 cases seen in a year]. Dakar Med. 1999;44:243–245.
Goldstein BG, Goldstein AO. Scabies: epidemiology, clinical features, and diagnosis. UpToDate. Available from: https://medilib.ir/uptodate/show/4038 (last accessed 09 December 2023).
Yanes DA, Faith EF. Nodular scabies: a persistent nodular eruption. Dermatol Online J. 2018;24:13030.
Suresh R, Raffi J, Murase J, Butler D. Scabies in the elderly. Int J Women's Dermatol. 2019;5:282–283.
Orkin M. Scabies in AIDS. Semin Dermatol. 1993;12:9–14.
Jannic A, Bernigaud C, Brenaut E, Chosidow O. Scabies itch. Dermatol Clin. 2018;36:301–308.
Nair PA, Vora RV, Jivani NB, Gandhi SS. A study of clinical profile and quality of life in patients with scabies at a rural tertiary care centre. J Clin Diagn Res. 2016;10:WC01–WC05.
Durdu M, Yürekli A. Uyuzun tanısı. In: Uzun S, Durdu M, editors. Her Yönüyle Uyuz. Antalya: Kongre Kitabevi; 2023. p. 81–100.
Yürekli A, Can İ, Oğuz M. Using ultraviolet light in diagnosing scabies: scabies' sign via Wood's lamp. J Am Acad Dermatol. 2023;89:e195–e196.
Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394:81–92.
Shoukat Q, Rizvi A, Wahood W, Coetzee S, Wrench A. Sight the mite: a meta‐analysis on the diagnosis of scabies. Cureus. 2023;15:e34390.
Zorbozan O, Türk BG, Acar A, Oraloğlu G, Ünver A, Töz S, et al. Comparison of skin scraping and standard superficial skin biopsy in the laboratory diagnosis of scabies. Turkiye Parazitol Derg. 2020;44:164–167.
Neynaber S, Muehlstaedt M, Flaig MJ, Herzinger T. Use of superficial cyanoacrylate biopsy (SCAB) as an alternative for mite identification in scabies. Arch Dermatol. 2008;144:114–115.
Katsumata K, Katsumata K. Simple method of detecting Sarcoptes scabiei var hominis mites among bedridden elderly patients suffering from severe scabies infestation using an adhesive‐tape. Intern Med. 2006;45:857–859.
Errichetti E. Dermoscopy in monitoring and predicting therapeutic response in general dermatology (Non‐tumoral dermatoses): an up‐to‐date overview. Dermatol Ther (Heidelb). 2020;10:1199–1214.
Dupuy A, Dehen L, Bourrat E, Lacroix C, Benderdouche M, Dubertret L, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol. 2007;56:53–62.
Wolfe C, Rudd E, Ng J, Weir J, Fuller LC. An unusual dermoscopic appearance of scabies. Br J Dermatol. 2021;185:e69.
Trane L, Scarfì F, Silvestri F, Venturi F, Pisano L, De Giorgi V. Fluorescence advanced videodermatoscopy for the rapid and safe diagnosis of misdiagnosed scabies. Photodermatol Photoimmunol Photomed. 2021;37:230–232.
Chavez‐Alvarez S, Villarreal‐Martinez A, Argenziano G, Ancer‐Arellano J, Ocampo‐Candiani J. Noodle pattern: a new dermoscopic pattern for crusted scabies (Norwegian scabies). J Eur Acad Dermatol Venereol. 2018;32:e46–e47.
Kaur I, Jakhar D. Transillumination dermoscopy of finger web spaces for scabies. J Am Acad Dermatol. 2020;82:e87–e88.
Nie J, Gou T, Xu L, Wang W, Zhang L, Lu Y. Misdiagnosed scabies correctly diagnosed by dermoscopy using ultraviolet light mode. Clin Exp Dermatol. 2021;46:1601–1603.
Yürekli A. A new sign with UV dermoscope in the diagnosis of scabies: ball sign. Skin Res Technol. 2023;29:e13336.
Ertugrul G, Aktas H. Comparison of sulfur ointment and permethrin treatments in scabies. Dermatol Ther. 2022;35:e15897.
Yürekli A. Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies. Dermatol Ther. 2022;35:e15260.
Thadanipon K, Anothaisintawee T, Rattanasiri S, Thakkinstian A, Attia J. Efficacy and safety of antiscabietic agents: a systematic review and network meta‐analysis of randomized controlled trials. J Am Acad Dermatol. 2019;80:1435–1444.
Porto I. Antiparasitic drugs and lactation: focus on anthelmintics, scabicides, and pediculicides. J Hum Lact. 2003;19:421–425.
Thomas C, Rehmus W, Chang AY. Treatment practices in the management of scabies in infants younger than two months. Pediatr Dermatol. 2021;38:431–435.
Goksugur SB, Karatas Z, Goksugur N, Bekdas M, Demircioglu F. Metabolic acidosis in an infant associated with permethrin toxicity. Pediatr Dermatol. 2015;32:e15–e17.
Hoffmann JC, Mößner R, Schön MP, Lippert U. Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months. J Dtsch Dermatol Ges. 2019;17:597–600.
Modi K, Patel D, Shwayder T. Scalp‐to‐toes application of permethrin for patients with scabies. Dermatol Online J. 2018;24:13030.
Veraldi S, De Micheli P, Schianchi R, Pontini P. A new treatment regimen with permethrin in scabies. G Ital Dermatol Venereol. 2018;153:491–493.
Durdu M. Uyuzun topikal tedavisi. In: Uzun S, Durdu M, editors. Her Yönüyle Uyuz. Antalya: Kongre Kitabevi; 2023. p. 135–145.
Elgart ML. A risk‐benefit assessment of agents used in the treatment of scabies. Drug Saf. 1996;14:386–393.
Roos TC, Alam M, Roos S, Merk HF, Bickers DR. Pharmacotherapy of ectoparasitic infections. Drugs. 2001;61:1067–1088.
Balsam of Peru in the treatment of scabies. Hospital (Lond 1886). 1907;41:426–427.
Seo SM, Park HM, Park IK. Larvicidal activity of ajowan (Trachyspermum ammi) and Peru balsam (Myroxylon pereira) oils and blends of their constituents against mosquito, Aedes aegypti, acute toxicity on water flea, Daphnia magna, and aqueous residue. J Agric Food Chem. 2012;60:5909–5914.
King RE. The benzyl benzoate treatment of scabies. Br Med J. 1940;2:626–627.
Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahé A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ. 2009;87:424–430.
Mytton OT, McGready R, Lee SJ, Roberts CH, Ashley EA, Carrara VI, et al. Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG. 2007;114:582–587.
Crotamiton. [WWW document]. https://reference.medscape.com/drug/eurax-crotamiton-topical-343500 Accessed 9 Dec 2023
Cubela V, Yawalkar SJ. Clinical experience with crotamiton cream and lotion in treatment of infants with scabies. Br J Clin Pract. 1978;32:229–231.
Konstantinov D, Stanoeva L, Yawalkar SJ. Crotamiton cream and lotion in the treatment of infants and young children with scabies. J Int Med Res. 1979;7:443–448.
Rao MA, Raza N, Faheem M, Saleem MA. Comparison of efficacy of permethrin 5% cream with crotamiton 10% cream in patients with scabies. J Ayub Med Coll Abbottabad. 2019;31:230–232.
Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2000;2:CD000320.
Goldust M, Rezaee E, Raghifar R. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies. Cutan Ocul Toxicol. 2014;33:333–336.
Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010;362:717–725.
Guzzo CA, Furtek CI, Porras AG, Chen C, Tipping R, Clineschmidt CM, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol. 2002;42:1122–1133.
Miyajima A, Hirota T, Sugioka A, Fukuzawa M, Sekine M, Yamamoto Y, et al. Effect of high‐fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies. J Dermatol. 2016;43:1030–1036.
Morgado‐Carrasco D, Piquero‐Casals J, Podlipnik S. Tratamiento de la escabiosis [Treatment of scabies]. Aten Primaria. 2022;54:102231.
Kentley J, Fuller LC. Ivermectin. In: Wakelin SH, Maibach HI, Archer CB, editors. Handbook of systemic drug treatment in dermatology. 3rd ed. Oxon: CRC Press; 2023. p. 159–163.
Romani L, Whitfield MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015;373:2305–2313.
Del Mar Saez‐De‐Ocariz M, McKinster CD, Orozco‐Covarrubias L, Tamayo‐Sánchez L, Ruiz‐Maldonado R. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin. Clin Exp Dermatol. 2002;27:264–267.
Levy M, Martin L, Bursztejn AC, Chiaverini C, Miquel J, Mahé E, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2020;182:1003–1006.
Jittamala P, Monteiro W, Smit MR, Pedrique B, Specht S, Chaccour CJ, et al. A systematic review and an individual patient data meta‐analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication? PLoS Negl Trop Dis. 2021;15:e0009144.
Wilkins AL, Steer AC, Cranswick N, Gwee A. Question 1: is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? Arch Dis Child. 2018;103:514–519.
Ziver tablet kısa ürün bilgisi dökümanı. Available from: https://titck.gov.tr/storage/Archive/2022/kubKtAttachments/UYGUNKB22.11.22_ca4cabaa‐9373‐4854‐b350‐f691a95076d0.pdf (last accessed 11 December 2023).
Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31:1248–1253.
Nicolas P, Maia MF, Bassat Q, Kobylinski KC, Monteiro W, Rabinovich NR, et al. Safety of oral ivermectin during pregnancy: a systematic review and meta‐analysis. Lancet Glob Health. 2020;8:e92–e100.
Weill A, Bernigaud C, Mokni M, Gil S, Elefant E, Chosidow O. Scabies‐infested pregnant women: a critical therapeutic challenge. PLoS Negl Trop Dis. 2021;15:e0008929.
CDC, STI Tx quick guide, scabies. Available from: https://www.cdc.gov/stiapp/scabies.html (last accessed 11 December 2023)
Sunderkötter C, Feldmeier H, Fölster‐Holst R, Geisel B, Klinke‐Rehbein S, Nast A, et al. S1 guidelines on the diagnosis and treatment of scabies ‐ short version. J Dtsch Dermatol Ges. 2016;14:1155–1167.
Mounsey KE, Murray HC, King M, Oprescu F. Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward. Epidemiol Infect. 2016;144:2462–2471.
Mueller SM, Gysin S, Schweitzer M, Schwegler S, Haeusermann P, Itin P, et al. Implementation and evaluation of an algorithm for the management of scabies outbreaks. BMC Infect Dis. 2019;19:200.